Jocelyn Aspa

Jocelyn obtained her diploma in journalism from Langara College in April 2016, just prior to joining INN as a staff writer for the resource sector. Since then, Jocelyn has shifted to covering the life science space and has become managing editor for INN's technology, cannabis and life science divisions. Jocelyn is passionate about niche topics within the life science sector and enjoys shedding light on companies focused on unmet clinical needs.

Prior to joining INN, Jocelyn interned at the Georgia Straight and blogged about the Vancouver Canucks. Before following her career in journalism, Jocelyn spent several years working in law firms. She thrives off the knowledge her background brings to her reporting.


5 Top NASDAQ Biotech and Pharma Stocks: Neoleukin Up 98 Percent

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...

December 15th, 2019

Biotech Trends 2019: M&A Slows, CNS Therapies Make Headlines

2019 marked another critical year of growth for the biotech market. Learn about key biotech trends before the new year...

December 12th, 2019

BioXcel Therapeutics to Expand BXCL701 Study

The company has announced it will advance its evaluation of BXCL701 into multiple advanced solid tumors in its Phase 2...

December 11th, 2019

Dare Biosciences and FDA Align on Phase 2b Study Design of Sildenafil

The company announced that it and the US Food and Drug Administration have reached an alignment for its Phase 2b...

December 11th, 2019

Avenue Therapeutics Submits New Drug Application for IV Tramadol

The company submitted a new drug application to the US Food and Drug Administration for its treatment IV tramadol.

December 11th, 2019

MacroGenics Presents Results from SOPHIA Study

The company reported results from its Phase 3 SOPHIA study in patients with HER2-positive metastatic breast cancer.

December 11th, 2019

5 Top Genetics News Stories of 2019

What caught the attention of readers in the genetics market this year? We've compiled a list of our top genetics...

December 10th, 2019